US 12,203,097 B2
Preparation of retinal pigment epithelium cells
Osnat Bohana-Kashtan, Tel-Mond (IL); and Ofer Wiser, Jerusalem (IL)
Assigned to CELL CURE NEUROSCIENCES LTD., Jerusalem (IL)
Filed by Cell Cure Neurosciences LTD, Jerusalem (IL)
Filed on Jun. 22, 2021, as Appl. No. 17/355,093.
Application 17/355,093 is a division of application No. 15/750,108, granted, now 11,066,642, previously published as PCT/IL2016/050857, filed on Aug. 4, 2016.
Claims priority of provisional application 62/253,738, filed on Nov. 11, 2015.
Claims priority of provisional application 62/201,156, filed on Aug. 5, 2015.
Prior Publication US 2021/0388316 A1, Dec. 16, 2021
Int. Cl. C12N 5/079 (2010.01)
CPC C12N 5/0621 (2013.01) [C12N 2500/38 (2013.01); C12N 2500/98 (2013.01); C12N 2501/115 (2013.01); C12N 2501/15 (2013.01); C12N 2506/02 (2013.01); C12N 2533/52 (2013.01); C12N 2533/54 (2013.01)] 20 Claims
 
1. A method of generating retinal pigment epithelial (RPE) cells comprising:
a) differentiating a population of human pluripotent stem cells in a medium comprising nicotinamide, in the absence of activin A, under non-adherent conditions to generate a cluster of cells comprising differentiating cells;
b) further differentiating said differentiating cells of (a) in a medium comprising nicotinamide, in the absence of activin A under adherent conditions;
c) further differentiating the population of differentiating cells in a culture comprising a medium comprising one or more members of the TGFβ superfamily, thereby generating a mixed population of cells comprising RPE cells;
d) enzymatically removing said mixed population of cells from said culture without mechanical isolation of cells, wherein more than 10% of the cells of said mixed populations of cells are non-pigmented cells; and
e) expanding said mixed population of cells to generate an expanded population of RPE cells.